000 03058nam a2200433 i 4500
999 _c394809
_d394809
001 394809
003 ES-MaUEC
005 20230109112617.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220726s2022 si a o |||| 0|eng d
020 _a9789811926150
024 7 _a10.1007/978-981-19-2615-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC848.C5
_b2022 EB
245 1 0 _aPharmacotherapy for Liver Cirrhosis and Its Complications
_cedited by Xingshun Qi, Yongping Yang
250 _a1st edition 2022
264 1 _aSingapore
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XII, 240 páginas)
_b20 ilustraciones, 16 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
505 0 _aAnti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.
520 _aThis book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9667204
_aCirrosis hepática
_xTratamiento
650 7 _2embne
_9671142
_aFarmacoterapia
700 1 _aQi, Xingshun
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aYang, Yongping
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9789811926143
776 0 8 _iPrinted edition:
_z9789811926167
776 0 8 _iPrinted edition:
_z9789811926174
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-2615-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2023
_dz
_eb
_zSI